Experiences of Early Postnatal Discharge Home as Perceived by Mothers and Healthcare Professionals (BbDom94)

February 16, 2026 updated by: Centre Hospitalier Intercommunal Creteil

Expériences du Retour à Domicile Post-natal précoce Par Les mères et Les Professionnels de santé : enquête Qualitative Sur Les Pratiques et Besoins

In recent years, the average length of stay in maternity units has decreased, leading to the development of early postnatal discharge home (EPDH) programs. Postnatal follow-up is a major public health issue, as it supports the physical and psychological well-being of mothers and newborns, helps parents adjust to their new roles, and promotes health prevention and education.

International studies show that mothers expect longer and more comprehensive follow-up, particularly regarding child development, sexuality, contraception, and returning to work. In France, EPDH has existed since the early 2000s and is offered to low-risk mothers and newborns shortly after birth, with two or three follow-up visits at home or in healthcare facilities.

As these programs are expected to expand, there is a need to better understand the experiences and needs of both mothers and healthcare professionals. This qualitative study, conducted in the Val-de-Marne department, aims to explore how they experience early discharge at individual, organizational, and medical levels. It seeks to identify the factors that contribute to positive or negative postnatal experiences and to compare local findings with existing international research.

Study Overview

Detailed Description

In recent years, the average length of stay in maternity units has decreased, and various early postnatal discharge home programs have been implemented. From a public health perspective, postnatal follow-up involves multiple challenges: it helps ensure the physical and psychological well-being of both mother and child and provides parents with support in caring for their newborn. During a period of vulnerability, it supports parents in their new roles while also contributing to health promotion and prevention (health behaviors, intra-family violence, etc.).

At the international level, several studies have identified the expectations of mothers and parents, who report a need for longer follow-up focused on child development, sexuality, contraception, and return to work.

In France, early postnatal discharge home (EPDH) has existed since the early 2000s. It is offered to low-risk women and newborns (as defined by the French National Authority for Health), two days after a vaginal birth and three days after a cesarean section. The program includes two or three follow-up visits, either at home or in a healthcare setting.

Early postnatal discharge programs are expected to expand as part of the reorganization of peri- and postnatal care, which requires the development of community-based services enabling mothers to access healthcare professionals as close as possible to their homes. This entails gaining a better understanding of the actual needs of mothers and healthcare professionals across different regions, which are characterized by considerable diversity.

This study is conducted in order to document the needs of mothers and healthcare professionals who experience early postnatal discharge home (EPDH) in the Val-de-Marne department.

It is a qualitative study that does not aim to test a hypothesis, but rather to document lived experiences in order to propose explanatory hypotheses. Accordingly, the study is grounded in the following research questions:

  • How do healthcare professionals and mothers experience early postnatal discharge home in Val-de-Marne, at the individual, collective, organizational, familial, and medical levels, among others?
  • According to them, what are the dimensions of a positive or negative postnatal experience? What are their needs and expectations?
  • Do the experiences of mothers and healthcare professionals (as documented in this study) overlap with those identified in the predominantly international literature, or do they differ?

Study Type

Observational

Enrollment (Estimated)

70

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Mothers Home care professionals Key witnesses (doctors, associations, researchers, etc.)

Description

Selection of Maternity

Inclusion Criteria:

  • Public maternity unit in Val-de-Marne offering mothers early discharge home and willing to participate

Exclusion Criteria:

  • Maternity unit opposed to participation

Selection of Home Care Professionals

Inclusion Criteria:

-Healthcare professional involved in the follow-up of early postnatal discharge home for women in Val-de-Marne and willing to participate in the study

Inclusion Criteria:

-Person with expertise in early return home and willing to participate

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The results of the thematic data analysis (see above "Data Analysis").
Time Frame: Eight months
The study triangulates sources by collecting observations, individual interviews, and group interviews. All collected data are analyzed thematically and inductively, meaning that themes are developed dynamically by the researchers. The analysis is conducted by two researchers and regularly discussed with the scientific committee
Eight months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Edouard LECARPENTIER, Pr, Centre Intercommunal de Créteil
  • Principal Investigator: Emmanuelle LAUMONDE, Midwife, Hôpitaux Paris Est Val-de-Marne (Site Saint-Maurice)
  • Principal Investigator: Fabienne PIGEARD, Midwife, Centre Intercommunal de Villeneuve-Saint-George

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

March 1, 2026

Primary Completion (Estimated)

August 1, 2027

Study Completion (Estimated)

August 1, 2027

Study Registration Dates

First Submitted

February 16, 2026

First Submitted That Met QC Criteria

February 16, 2026

First Posted (Actual)

February 23, 2026

Study Record Updates

Last Update Posted (Actual)

February 23, 2026

Last Update Submitted That Met QC Criteria

February 16, 2026

Last Verified

February 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Health Services Research

Clinical Trials on The study is qualitative, prospective, and multicenter. Participation is offered to centers and individuals with experience of early postnatal discharge home who meet the inclusion criteria

  • Institut de Médecine et d'Epidémiologie Appliquée...
    ANRS, Emerging Infectious Diseases
    Withdrawn
    HIV1 Infection | Multi-treated Patients Who Have Received Multiple Lines of Antiretroviral Treatment | CABOTEGRAVIR | LENACAPAVIR | Stable Oral Antiretroviral Treatment for at Least 6 Months
    France
Subscribe